Latest news
25 items- PRVA STAND Act introduced in the United States SenateMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 22, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today applauded the introduction of a Senate companion bill to H.R. 6373, the VA Spinal Trauma Access to New Devices (STAND) Act. The Senate companion bill was introduced by Chairman of the Senate Veterans' Affairs Committee, Senator Jon Tester (D-MT), and the Ranking Member of that committee, Senator Jerry Moran (R-KS).
- PRLifeward Announces Reverse Share SplitReverse split initiated to regain compliance with Nasdaq listing requirements Financial guidance for 2024 and profitability target for 2026 on existing capital remain unchanged MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced that effective with the open of the market on Friday, March 15, 2024, the Company will complete a 1-for-7 reverse
- PRReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke TherapyRandomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to a matched control group receiving conventional stroke therapy. Additional study demonstrates that the improvements in walking speed and distance following high-intensity gait training with the ReStore Exo-Suit were maintained by individuals post-stroke 4 weeks after the intervention had concluded. Combined results highlight the clinical value of the ReStore Exo-Suit and its related breakthrough propulsion-augmenting technologies within the Lifeward product development pipeline. MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, M
- PRLifeward announces the Centers for Medicare & Medicaid Services ("CMS") is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be consideredThe decision was communicated through CMS' bi-annual Healthcare Common Procedure Coding System ("HCPCS") coding memorandum released yesterday; payment amount determination for ReWalk Personal Exoskeletons will continue to be on a case-by-case basis until such determination is finalized, likely later this year. To date, Lifeward has delivered 35 Personal Exoskeletons to Medicare beneficiaries in an initiative to establish necessary capabilities and processes to support growing demand MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 01, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-
- PRLifeward Reports Fourth Quarter and Full Year 2023 Financial ResultsHighest quarterly and annual revenue in the history of LifewardCommercial and operational integration complete; synergiesexpected to yield $3 million in annual net savings MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced its financial results for the three months and full year ended December 31, 2023. Highlights of the Fourth Quarter of 2023 and Early 2024
- PRLifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward™), (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced that the Company will release its fourth quarter and fiscal year-end 2023 financial results before the markets open on Tuesday, February 27, 2024. Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EST to discuss the f
- SECReWalk Robotics Ltd. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - ReWalk Robotics Ltd. (0001607962) (Filer)
- PRReWalk Robotics Transforms Company Identity, Rebrands as LifewardLifeward brand reflects the Company's commitment to pioneering innovative technology to empower the pursuit of life's ambitions in the face of physical limitation or disability The complete rebrand includes new name, stock ticker, logo, website launch, and corporate messaging MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 29, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk") today unveiled its new corporate branding to officially begin doing business as Lifeward™ ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's
- PRReWalk Robotics Expands Direct Sales Coverage to CanadaMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 12, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, announced today that the Company is expanding its direct sales coverage to Canada. This expansion occurs as the result of the integration between the former ReWalk and AlterG commercial teams following the recent acquisition, which has resulted in a more extensive sales force with increased capacity. "With the formation of our larger, newly combined commercial team, we have expand
- PRReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Jan. 11, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company") announced that Larry Jasinski, Chief Executive Officer, and Mike Lawless, Chief Financial Officer, will provide an overview presentation and host one-on-one meetings with investors at the Sidoti January Virtual Investor Conference, taking place on January 17-18, 2024. The presentation will begin at 2:30 PM EST on January 17, 2024 and can be accessed live here: https://sidoti.zoom.us/webinar/register/WN_ZpcK-ahiRLabYaQ5ySQKsw. ReWalk will also host virtual one-on-ones with investors on Wednesday and Thursday, January 17-18, 2023. Registrat
- PRFirst ReWalk Personal Exoskeleton Claim Paid by MedicareMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 05, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced that it has received payment from Noridian Healthcare Solutions ("Noridian"), a Medicare Administrative Contractor ("MAC"), for its first claim for the ReWalk Personal Exoskeleton. This marks coverage and payment by Medicare fee-for-service for the first-ever claim submitted for a ReWalk Personal Exoskeleton device. This milestone reflects an acknowledgement by Medicare that the Re
- NEWSReWalk Robotics Says Implementing A Cost Structure Optimization Plan Which Includes A 15% Reduction In Force Implemented At The End Of 2023
- PRReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational PrioritiesMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 04, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company"), today issued an open letter from Larry Jasinski, Chief Executive Officer, to shareholders detailing transformational achievements in 2023 and commercial and operating priorities for 2024. The full letter is published below: Dear Shareholders, On behalf of ReWalk and our Board of Directors, I want to wish everyone a happy, healthy, and safe new year. From the outset of ReWalk's founding, the Company has collectively poured its collaborative efforts into manifesting our founder's dream: To deliver on the promise to fundamentally improve
- SECReWalk Robotics Ltd. filed SEC Form 8-K: Other Events8-K - ReWalk Robotics Ltd. (0001607962) (Filer)
- PRReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public MeetingMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Nov. 30, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, presented at the Healthcare Common Procedure Coding System ("HCPCS") public meeting on November 29, 2023 and provided feedback to the Centers for Medicare & Medicaid Services ("CMS") regarding the preliminary payment determination for the code describing the ReWalk Personal Exoskeleton. "Yesterday's meeting was an opportunity for us to show our appreciation for the significant pr
- NEWSReWalk Robotics Demonstrates AI Autonomous Decision Making In Next Generation Exoskeleton PrototypeReWalk Robotics, Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, announced the successful demonstration of a proof-of-concept next-generation exoskeleton. As part of the Israel Innovation Authority's MAGNET incentive program, the Human Robot Interaction Consortium (the "HRI Consortium"), the company has reached a milestone by integrating advanced sensing technologies and artificial intelligence ("AI") to enable autonomous decision making in the Company's latest exoskeleton prototype. "We have successfully demonstrated that by combining
- PRReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton PrototypeMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Nov. 28, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, announced the successful demonstration of a proof-of-concept next-generation exoskeleton. As part of the Israel Innovation Authority's MAGNET incentive program, the Human Robot Interaction Consortium (the "HRI Consortium"), the company has reached a milestone by integrating advanced sensing technologies and artificial intelligence ("AI") to enable autonomous decision making in th
- INSIDERLind Global Fund Ii Lp bought $40,089 worth of Ordinary Shares (54,917 units at $0.73) (SEC Form 4)4 - ReWalk Robotics Ltd. (0001607962) (Issuer)
- INSIDERLind Global Fund Ii Lp bought $49,516 worth of Ordinary Shares (72,818 units at $0.68) (SEC Form 4)4 - ReWalk Robotics Ltd. (0001607962) (Issuer)
- NEWSHC Wainwright & Co. Reiterates Buy on ReWalk Robotics, Maintains $3 Price TargetHC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ReWalk Robotics (NASDAQ:RWLK) with a Buy and maintains $3 price target.
- NEWSEarnings Scheduled For November 14, 2023Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue of $18.00 million. • Caledonia Mining (AMEX:CMCL) is expected to report earnings for its third quarter. • Argo Blockchain (NASDAQ:ARBK) is estimated to report quarterly loss at $0.12 per share on revenue of $13.28 million. • SuperCom (NASDAQ:SPCB) is estimated to report quarterly earnings at $0.00 per share on revenue of $4.60 million. • Moving iMage Technologies (AMEX:MITQ) is projected to report earnings for its first quarter. • Eagle Pharmaceuticals (NASDAQ:EGRX) is likely to report quarterly earnings at $1.06 per share on revenue of $62.60 million. • 2sevent
- NEWSReWalk Robotics Q3 2023 Adj. EPS $(0.08) Beats $(0.11) Estimate, Revenue $4.4M Beats $4.3M Estimate'`
- PRReWalk Robotics Reports Third Quarter 2023 Financial ResultsRecord Quarterly Revenue of $4.4 Million Successful Completion of AlterG Acquisition and Significant Progress of Integration Major Advancement in Efforts to Attain Medicare Payment Coverage of Exoskeletons MARLBOROUGH, Mass., BERLIN and YOKNEAM ILLIT, Israel, Nov. 14, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its financial results for the three and nine months ended September 30, 2023. Highlights of the Third Quarter of 2023 include: Closing of ReWalk's acquisition o
- NEWSPreview: ReWalk Robotics's EarningsReWalk Robotics (NASDAQ:RWLK) is set to give its latest quarterly earnings report on Tuesday, 2023-11-14. Here's what investors need to know before the announcement. Analysts estimate that ReWalk Robotics will report an earnings per share (EPS) of $-0.11. ReWalk Robotics bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter. New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast). Historical Earnings Performance Last quarter the company missed EPS by $0.01, which was followed by a 0.0% drop
- PRNew Bill Facilitates Veteran Access to Powered ExoskeletonsMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Nov. 10, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, applauded new legislation that will be introduced in the U. S. House of Representatives that will enhance the opportunity for clinically-eligible U.S. Veterans to gain access to powered exoskeletons, and ensure the U.S Department of Veterans' Affairs ("VA") is delivering the technology in both a routine and timely manner. The new bi-partisan bill, titled the Veterans Spinal Trauma A
RWLK FAQ
6 questionsWhat does ReWalk Robotics Ltd. do?
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes wearable robotic exoskeletons for individuals with mobility impairments or other medical conditions in Israel, the United States, Europe, the Asia-Pacific, Latin America, and Africa. It offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for used in the rehabilitation of individuals with lower limb disability due to stroke; and MyoCycle and MediTouch tutor movement biofeedback...Where does RWLK stock trade?
ReWalk Robotics Ltd. (RWLK) is listed on NASDAQ.What sector and industry is RWLK in?
ReWalk Robotics Ltd. operates in the Health Care sector, Industrial Specialties industry.When did ReWalk Robotics Ltd. go public?
ReWalk Robotics Ltd. (RWLK) completed its IPO in 2014.What companies are similar to RWLK?
Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), ZBH (Zimmer Biomet Holdings Inc.), MAS (Masco Corporation). Compare RWLK side-by-side with any of them on Quantisnow.How can I track RWLK on Quantisnow?
Quantisnow aggregates ReWalk Robotics Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RWLK to receive live email and push alerts on every new disclosure.